Efficay Of Kutaj Vati In Garbhini Mutrakricchra (Uti In Pregnancy)

Abstract

Garbhini Mutrakricchra, correlating clinically with urinary tract infections in pregnancy, arises from Vata-Pitta imbalance affecting the Mutravaha Srotas, compounded by physiological changes of gestation such as urinary stasis and hormonal influences. In a study predominantly involving women aged 26–30 years, mostly multiparas in their third trimester, the majority (91%) presented with painful, burning, and frequent urination, confirming the clinical burden of this condition. Kutaj Vati administered with Godugdha over five days showed remarkable therapeutic outcomes, with a significant reduction in painful micturition (66.67%), burning sensation (80.64%), and urinary frequency (77.5%), attributable to its Pitta-shamaka, Shothahara, and Vata-balancing actions. Objective markers supported these improvements, with a 15.96% reduction in TLC, 7.09% decrease in neutrophil count, and a substantial 63.73% decline in urine pus cells, highlighting Kutaj Vati’s antimicrobial, anti-inflammatory, and immunomodulatory effects.

The clinical study establishes Kutaj Vati as a safe, effective, and well-tolerated Ayurvedic intervention for Garbhini Mutrakricchra (urinary tract infections in pregnancy). It significantly reduces key symptoms such as pain, burning micturition, and urinary frequency, while objective improvements in leucocyte and pus cell counts confirm its infection-resolving potential. In the context of rising antibiotic resistance and the risks of teratogenicity with conventional agents, Kutaj Vati emerges as a viable alternative or adjunct in prenatal care. By integrating symptom relief with dosha balancing, antimicrobial, and anti-inflammatory actions, it highlights the translational value of Ayurvedic formulations in obstetric research and practice, positioning it as a promising supportive therapy in pregnancy-associated urinary tract disorders.